Skip to main content

Outage notice:

Due to the global information outage that occurred Friday, Quest is taking swift action to respond, recover and restore our operations. Our Patient Services are operating with reduced capacity so you may experience longer wait and service times. Our Customer Contact teams are currently unavailable. We appreciate your patience as we work toward returning to normal operations. 


Academic collaboration

We don’t just run tests, we help invent them

As a trusted authority in diagnostic medicine, we help clinicians zero in on a diagnosis and treatment. But that’s not all. Our scale, scientific and clinical expertise, and relationships with academic hospitals come together to help us lead, facilitate, and collaborate on a wide variety of medical and scientific research.

Collaborations that power better care

Quest Diagnostics and the University of Pittsburgh Medical Center 

This decades-long joint venture combines the research discoveries and capabilities of UPMC with Quest's national reach and technical and clinical development capabilities.

Our collaboration with UPMC is designed to meet the key needs of patient and physician populations in the communities in which we collectively operate through:

  • Accelerated access to academic-based biomedical research
  • Development of advanced diagnostics to improve patient care
  • Established residency rotations for education and training, as well as contributions to universities through adjunct positions

Read about a few of our current research collaborations

Providing genomic sequencing to identify new mutations in, and patterns of transmission of SARS-CoV-2, the virus that causes COVID-19 

One Brave Idea, co-founded by the American Heart Association and Verily, pursues unconventional scientific approaches to advance the fight against coronary heart disease. As a pillar supporter, we’re contributing biomarker implementation, population health analytics, and a national lab platform.

Working with Memorial Sloan Kettering Cancer Center (MSK), we’re using molecular lab testing to improve physicians’ ability to treat patients with breast, prostate, colon, lung, and a variety of other solid tumor cancers by giving them a better understanding of the genomic underpinnings of their patients’ illnesses. We’re collaborating with MSK to identify the biological effect, prevalence, prognostic information, and treatment implications for each oncologic variant.

Partnering to implement a new clinical pathway for dementia screening—created with the University of California San Francisco Memory and Aging Center—to reduce variation for better outcomes.

Providing primary lab and esoteric testing support for Yale New Haven Health and helping to manage patients throughout the system for better outcomes. Our medical experts are valued consultants and collaborators, working with Yale physicians to help diagnose and treat patients.

Unique diagnostic research activity in 2021


peer-reviewed publications by Quest authors


educational webinars and podcasts


clinical study abstracts and national meeting presentations


new tests